HURA
TuHURA Biosciences, Inc./NV
NASDAQ · Healthcare · Biotechnology · US
$1.78
+1.14%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-165.6%
Return on equity
-96.5%
Return on assets
-165.0%
Return on invested capital
0.00x
Asset turnover
-$29.7M
Cash from operations
$0.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026